Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 447

Sort by

Sort Order Select

Journal Articles

Updated Meta-Analysis of Randomized Controlled Trials on Primary Ambulatory Thromboprophylaxis (PATP) in Patients with Locally Advanced or Metastatic Lung Cancer Receiving Chemotherapy

Kyaw Zin Thein, MDMBBS, Lukman Tijani, MD, Thein H. Oo, MD

Blood (2019) 134 (Supplement_1): 2435.

https://doi.org/10.1182/blood-2019-123144

Published: 2019

Journal Articles

One- Week Prophylaxis with Enoxaparin after Hospital Discharge Is Effective in Preventing Venous Thromboembolism in Living Liver Donors- Single Institution Retrospective Analysis

Leila Khaddour, MD, Zaid Al Saheli, MD, Yaser Alkhatib, MD, Marwan Abouljoud, MD, Philip Kuriakose, MD

Blood (2019) 134 (Supplement_1): 2442.

https://doi.org/10.1182/blood-2019-124169

Published: 2019

Journal Articles

Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial

Alex C. Spyropoulos, MD, Gary E. Raskob, PhD, Alexander T Cohen, MBBS, MSc, MD, Walter Ageno, Jeffrey I. Weitz, MD, Theodore E. Spiro, MD, Wentao Lu, PhD, Concetta Lipardi, MD PhD, Elliot S. Barnathan, MD

Blood (2019) 134 (Supplement_1): 2441.

https://doi.org/10.1182/blood-2019-122930

Published: 2019

Journal Articles

Anticoagulation Increases Bleeding Rates in Portal Vein Thrombosis: A National Database Study

Omar Ali Alaber, MD, Apoorva Krishna Chandar, MDMPH, Basma Ali Dahash, MD, Sohi N Mistry, BS, Stanley Martin Cohen, MD, Amitabh Chak, MD, Ankit Mangla, MBBS, MD

Blood (2019) 134 (Supplement_1): 5860.

https://doi.org/10.1182/blood-2019-131226

Published: 2019

Journal Articles

A Pilot Study of an Oral Anticoagulant, Apixaban, in Secondary Prophylaxis of Venous Thromboembolism (VTE) in Children and Adolescents

Ashley Pinchinat, MD, Neida Otero, Harshini Mahanti, BS, MSCR, Erin Morris, RN, BSN, Adele Brudnicki, MD, Deborah Friedman, MD, Simon Li, MD, Oya Levendoglu-Tugal, MD, Mitchell S Cairo, MD

Blood (2019) 134 (Supplement_1): 2443.

https://doi.org/10.1182/blood-2019-130468

Published: 2019

Journal Articles

Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis

Christopher Melani, MD, Rahul Lakhotia, MD, Stefania Pittaluga, MD PhD, Milos D. Miljkovic, MDMSc, Jagan R. Muppidi, MD PhD, Craig A. Portell, MD, Rafic Farah, MD, Seung Tae Lee, MD PhD, Anna Marie Juanitez, RN, Lydia L. Chou, CRNP, Seth M. Steinberg, PhD, Elaine S. Jaffe, MD, Louis Staudt, MD, Mark Roschewski, MD, Wyndham Wilson, MD

Blood (2019) 134 (Supplement_1): 2867.

https://doi.org/10.1182/blood-2019-125990

Published: 2019

Journal Articles

Real World Application of Thromboprophylaxis in Patients with Malignancy

Nicole Mischler, Nancy Fisher, MBA, Susan Frankii, MS, Attila J Kovacs, PhD, Lori Rosenstein, MD

Blood (2019) 134 (Supplement_1): 3394.

https://doi.org/10.1182/blood-2019-131383

Published: 2019

Journal Articles

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients

Fahrettin Covut, MD, Ramsha Ahmed, MD, Christy J. Samaras, DO, Faiz Anwer, MD, Alex V. Mejia Garcia, MD, Dana E Angelini, MD, Beth M. Faiman, PhDCNP, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Saveta Mathur, CNP, Kimberly Hamilton, APRN/PA, Nathaniel Rosko, PharmD, Jason Valent, MD, Jack Khouri, MD

Blood (2019) 134 (Supplement_1): 3148.

https://doi.org/10.1182/blood-2019-131400

Published: 2019

Journal Articles

Central Line-Associated Thrombus Formation in an Inhibitor Negative Severe Hemophilia A Patient on Emicizumab

Nicholas B George, MD, Alexander Paschke, Katie Scott, MD

Blood (2019) 134 (Supplement_1): 4938.

https://doi.org/10.1182/blood-2019-127105

Published: 2019

Journal Articles

One-Year Outcomes with Once or Twice Daily Enoxaparin

Adi J. Klil-Drori, MDMSc, Sara Nazha, PhD, Marlene Gharib, PhD, Sylvie Perreault, PhDBPharm, Vicky Tagalakis, MD FRCPC

Blood (2019) 134 (Supplement_1): 4968.

https://doi.org/10.1182/blood-2019-127106

Published: 2019

Journal Articles

Comparison of Low Molecular Weight Heparin Activity Assays with and without Addition of Exogenous Antithrombin in a Pediatric and Young Adult Leukemia Cohort

Beverly Schaefer, MD, Adriane Hausfeld, Paul Steele, MD, Jan Martin, Sandra Brannon, Adam Lane, PhD, Lori Luchtman-Jones, MD

Blood (2019) 134 (Supplement_1): 4915.

https://doi.org/10.1182/blood-2019-123716

Published: 2019

Journal Articles

Recurrent Venous and Arterial Thrombosis By Prothrombin p.R596Q Heterozygous Mutation in a Chinese Patient: A Case Report and Literature Review

Rong-Fu Zhou, PhD MD, WANG JUN, MD, Xu Peng, MD, Hui Zeng, MD, Yong Xu, PhD, Yueyi Xu, MD, Min Zhou, Peipei Xu, Bing Chen

Blood (2019) 134 (Supplement_1): 4947.

https://doi.org/10.1182/blood-2019-130459

Published: 2019

Journal Articles

Effects of Andexanet Alfa on Thrombin Generation in Bleeding Associated with Factor Xa Inhibitors

Michiel Coppens, MD, Lizhen Xu, PhD, Roisin Bavalia, MD, Saskia Middeldorp, MD PhD, Peter Verhamme, MD PhD, John W. Eikelboom, MBBS, MSc, FRACP, FRCPA, Mark Crowther, MD, Genmin Lu, Patrick Yue, MD, Pamela B. Conley, PhD, Stuart J. Connolly, MD MSc, FRCPC

Blood (2019) 134 (Supplement_1): 711.

https://doi.org/10.1182/blood-2019-124596

Published: 2019

Journal Articles

Monitoring the "Lifetime" of a Thrombus over Long Timescales By Leveraging a Novel Microvasculature-on-Chip Thrombosis Resolution Assay

Yongzhi Qiu, PhD, Yumiko Sakurai, MSc, Wilbur A. Lam, MD PhD

Blood (2019) 134 (Supplement_1): 441.

https://doi.org/10.1182/blood-2019-128718

Published: 2019

Journal Articles

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention

Andrew B Wilks, MD MS, Daniel Douce, MD, Steven Ades, MD, Mary Cushman, MD MSc, Neil A. Zakai, MD MSc, Chris E. Holmes, MD PhD

Blood (2019) 134 (Supplement_1): 709.

https://doi.org/10.1182/blood-2019-128831

Published: 2019

Journal Articles

Incidental Pulmonary Embolism. Analysis of Mayo Clinic Venous Thromboembolism Database

Ewa Wysokinska, MD, Damon E. Houghton, MDMS, Danielle Vlazny, PA-C, Aneel A. Ashrani, MD MS, David A Froehling, MD, David O. Hodge, MS, Lisa Peterson, RN, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD, Ana I Casanegra, MD

Blood (2019) 134 (Supplement_1): 1147.

https://doi.org/10.1182/blood-2019-131547

Published: 2019

Journal Articles

The Use of Direct Oral Anticoagulants in Non-Cirrhotic Portal Vein Thrombosis

Leonard Naymagon, MD, Douglas Tremblay, MD, Nicole Zubizarreta, MPH, Erin Moshier, MS, Thomas Schiano, MD, John Mascarenhas, MD

Blood (2019) 134 (Supplement_1): 1154.

https://doi.org/10.1182/blood-2019-124042

Published: 2019

Journal Articles

Characterizing the Use of Direct Oral Anticoagulants in Children Using the American Thrombosis and Hemostasis Network Dataset (ATHNdataset)

Jennifer G. Davila, MD, Dunlei Cheng, PhD, Leslie J. Raffini, MD, Courtney D. Thornburg, MD, Fernando F. Corrales-Medina, MD

Blood (2019) 134 (Supplement_1): 1156.

https://doi.org/10.1182/blood-2019-128324

Published: 2019

Journal Articles

Andexanet Alpha Differentially Neutralizes the Anticoagulant, Antiprotease and Thrombin Generation Inhibitory Effects of Unfractionated Heparin, Enoxaparin and Fondaparinux

Fakiha Siddiqui, Alfonso J Tafur, MD MS, Debra Hoppensteadt, PhD, Jeanine Walenga, PhD, Walter Jeske, PhD, Emily Bontekoe, Ahmed Kouta, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 1158.

https://doi.org/10.1182/blood-2019-127072

Published: 2019

Journal Articles

Safety and Efficacy of Apixaban Versus Enoxaparin/Warfarin in Patients with Extremes of Body Weight: Post-Hoc Analysis of the AMPLIFY Trial

Theodore Lee, MD, Sharon Pan, Wonkyung Byon, Bushra S Ilyas

Blood (2019) 134 (Supplement_1): 1152.

https://doi.org/10.1182/blood-2019-121542

Published: 2019

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Updated Meta-Analysis of Randomized Controlled Trials on Primary Ambulatory Thromboprophylaxis (PATP) in Patients with Locally Advanced or Metastatic Lung Cancer Receiving Chemotherapy

One- Week Prophylaxis with Enoxaparin after Hospital Discharge Is Effective in Preventing Venous Thromboembolism in Living Liver Donors- Single Institution Retrospective Analysis

Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial

Anticoagulation Increases Bleeding Rates in Portal Vein Thrombosis: A National Database Study

A Pilot Study of an Oral Anticoagulant, Apixaban, in Secondary Prophylaxis of Venous Thromboembolism (VTE) in Children and Adolescents

Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis

Real World Application of Thromboprophylaxis in Patients with Malignancy

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients

Central Line-Associated Thrombus Formation in an Inhibitor Negative Severe Hemophilia A Patient on Emicizumab

One-Year Outcomes with Once or Twice Daily Enoxaparin

Comparison of Low Molecular Weight Heparin Activity Assays with and without Addition of Exogenous Antithrombin in a Pediatric and Young Adult Leukemia Cohort

Recurrent Venous and Arterial Thrombosis By Prothrombin p.R596Q Heterozygous Mutation in a Chinese Patient: A Case Report and Literature Review

Effects of Andexanet Alfa on Thrombin Generation in Bleeding Associated with Factor Xa Inhibitors

Monitoring the "Lifetime" of a Thrombus over Long Timescales By Leveraging a Novel Microvasculature-on-Chip Thrombosis Resolution Assay

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention

Incidental Pulmonary Embolism. Analysis of Mayo Clinic Venous Thromboembolism Database

The Use of Direct Oral Anticoagulants in Non-Cirrhotic Portal Vein Thrombosis

Characterizing the Use of Direct Oral Anticoagulants in Children Using the American Thrombosis and Hemostasis Network Dataset (ATHNdataset)

Andexanet Alpha Differentially Neutralizes the Anticoagulant, Antiprotease and Thrombin Generation Inhibitory Effects of Unfractionated Heparin, Enoxaparin and Fondaparinux

Safety and Efficacy of Apixaban Versus Enoxaparin/Warfarin in Patients with Extremes of Body Weight: Post-Hoc Analysis of the AMPLIFY Trial

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only